Recombinant live fowlpox virus vectors and their use in pharmaceutical compositions against hepatitis C virus

Recombinant fowl pox virus expressing hepatitis C virus proteins and their use in pharmaceuticals compositions, able to induce a cellular immune response against the hepatitis C virus, alter administration of a reduced number of doses. The pharmaceutical compositions of this invention are useful for...

Full description

Saved in:
Bibliographic Details
Main Authors ALEXIS MUSACCHIO LASA, SANTIAGO DUENAS CARRERA, NELSON ACOSTA RIVERO, LIZ ALVAREZ-LAJONCHERE PONCE DE LEON, IVIS GUERRA AIZPURUA
Format Patent
LanguageEnglish
Published 16.02.2006
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Recombinant fowl pox virus expressing hepatitis C virus proteins and their use in pharmaceuticals compositions, able to induce a cellular immune response against the hepatitis C virus, alter administration of a reduced number of doses. The pharmaceutical compositions of this invention are useful for prevention and treatment of infections associated with the hepatitis C virus.
Bibliography:Application Number: AU20050270612